Jenny Barnett
Chief Executive Officer, Monument Therapeutics
Jenny is a cognitive neuroscientist and CEO of Monument Tx. She was previously Chief Scientific Officer at Cambridge Cognition where she led clinical trial, healthcare and R&D functions before spinning out Monument in 2021. She has an MA in Experimental Psychology from Oxford University, a PhD in the Epidemiology of Schizophrenia from the University of Cambridge, and completed post-doctoral work at Massachusetts General Hospital and the Broad Institute of Harvard and MIT. She is the author of more than 70 papers, six patents, and two popular science books and is an honorary member of the University of Cambridge Department of Psychiatry.
